EN zh-TW

newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / Markets Insider

Morgan Stanley maintains a Buy rating on Telix Pharmaceuticals, with a price target of A$24.60.

David Bailey from Morgan Stanley reaffirmed a Buy rating on Telix Pharmaceuticals with a A$24.60 target.

KEY POINTS
COMPANIES
Read the full story on Markets Insider → →
Share X LinkedIn

Summarized by Newsio from Markets Insider. How we summarize →

RELATED 03
business · news · 1h 140

The European Commission is investigating the $111 billion Paramount-WBD deal.

  • The EU is probing $24 billion in Middle Eastern funding of the Paramount-WBD merger under new subsidy rules.
  • Paramount disclosed Gulf States will own about 38.5% equity in the merged company but lack voting rights.
Variety →
business · news · 2h 136

U.S. entertainment giant sought EU approval under its Foreign SubsidiesRegulation.

  • Paramount Skydance Corp's $110 billion takeover of Warner Bros Discovery is under EU subsidy scrutiny.
  • The deal is backed by Saudi PIF, Abu Dhabi's L'imad Holding, and Qatar Investment Authority.
The Star →
business · news · 1h 127

Consumer-price growth remains at three-year highs.

  • The energy index surged 3.9% MoM in May, driving a 23% YoY increase mainly from oil.
  • Core CPI rose only 0.2% MoM, less than the 0.3% estimate, indicating limited underlying inflation.
Barchart →